Amar Patel
About Amar Patel
Current Position at Bristol Myers Squibb
Amar Patel is currently the Senior Director of Early Clinical Development, Immuno-Oncology & Cell Therapy at Bristol Myers Squibb. In this role, he leads the clinical development for multiple early phase assets with a focus on immuno-oncology. Additionally, he engages in business development activities and works on cell therapy projects. His work involves trial execution and oversight, contributing to clinical development strategy for various therapeutic treatment modalities.
Title at University of California, San Francisco
Amar Patel serves as an Assistant Clinical Professor of Hematology and Oncology at the University of California, San Francisco. He has held this position since concluding his fellowship, bringing his extensive experience in clinical development and oncology to the academic setting.
Previous Roles at Bristol Myers Squibb
Before assuming his current role, Amar Patel worked as the Director of Early Clinical Development, Immuno-Oncology & Cell Therapy at Bristol Myers Squibb from 2018 to 2021. During this period, he focused on leading various early phase clinical trials and contributed to the strategic planning of therapeutic treatment modalities in immuno-oncology.
Experience at University of California, San Francisco
Amar Patel was a Clinical Fellow in Hematology and Oncology at the University of California, San Francisco from 2015 to 2018. His fellowship provided him with robust training and experience in clinical research and patient care, laying the groundwork for his subsequent roles in clinical development.
Academic Background
Amar Patel earned his Doctor of Medicine (MD) from The Johns Hopkins University School of Medicine, where he studied from 2007 to 2011. Prior to this, he completed his Bachelor of Arts (BA) in Biochemical Sciences at Harvard University, graduating in 2006. His educational background has provided him with a strong foundation in medical science and research.